Determinants for the activation and autoinhibition of the diguanylate cyclase response regulator WspR.
The bacterial second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) controls secretion, cell adhesion, and motility, leading to biofilm formation and increased cytotoxicity. Diguanylate cyclases containing GGDEF and phosphodiesterases containing EAL or HD-GYP domains have been identified as the enzymes controlling cellular c-di-GMP levels, yet less is known regarding the molecular mechanisms governing regulation and signaling specificity. We recently determined a product-inhibition pathway for the diguanylate cyclase response regulator WspR from Pseudomonas, a potent molecular switch that controls biofilm formation. In WspR, catalytic activity is modulated by a helical stalk motif that connects its phospho-receiver and GGDEF domains. The stalks facilitate the formation of distinct oligomeric states that contribute to both activation and autoinhibition. Here, we provide novel insights into the regulation of diguanylate cyclase activity in WspR based on the crystal structures of full-length WspR, the isolated GGDEF domain, and an artificially dimerized catalytic domain. The structures highlight that inhibition is achieved by restricting the mobility of rigid GGDEF domains, mediated by c-di-GMP binding to an inhibitory site at the GGDEF domain. Kinetic measurements and biochemical characterization corroborate a model in which the activation of WspR requires the formation of a tetrameric species. Tetramerization occurs spontaneously at high protein concentration or upon addition of the phosphomimetic compound beryllium fluoride. Our analyses elucidate common and WspR-specific mechanisms for the fine-tuning of diguanylate cyclase activity.
De
Nabanita
N
Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Navarro
Marcos V A S
MV
Raghavan
Rahul V
RV
Sondermann
Holger
H
D020816:Amino Acid Motifs; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry; D001608:Beryllium / Q000494:pharmacology; D018360:Crystallography, X-Ray; D006152:Cyclic GMP / Q000031:analogs & derivatives; D004789:Enzyme Activation / Q000187:drug effects; D029968:Escherichia coli Proteins; D005459:Fluorides / Q000494:pharmacology; D007700:Kinetics; D008958:Models, Molecular; D050505:Mutant Proteins / Q000737:chemistry; D019761:Phosphorus-Oxygen Lyases / Q000378:metabolism*; D020836:Protein Structure, Quaternary; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D044224:Pseudomonas syringae / Q000201:enzymology*; D011993:Recombinant Fusion Proteins / Q000378:metabolism
D001426:Bacterial Proteins; D029968:Escherichia coli Proteins; D050505:Mutant Proteins; D011993:Recombinant Fusion Proteins; C035982:beryllium fluoride; C062025:bis(3',5')-cyclic diguanylic acid; D019761:Phosphorus-Oxygen Lyases; C060720:diguanylate cyclase; D006152:Cyclic GMP; D001608:Beryllium; D005459:Fluorides
Mol Microbiol. 2005 Jan;55(2):368-80
15659157
Microbiology (Reading). 2004 Aug;150(Pt 8):2497-2502
15289546
Genetics. 2006 Jun;173(2):515-26
16624907
Genes Dev. 2003 Oct 15;17(20):2552-63
14561776
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14789-94
10611291
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
12393927
Rev Physiol Biochem Pharmacol. 2006;157:105-40
17236651
J Bacteriol. 2005 Dec;187(24):8229-30
16321925
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):561-4
1988953
Protein Sci. 2005 Dec;14(12):3077-88
16322582
Annu Rev Biochem. 2000;69:183-215
10966457
J Biol Chem. 2006 Oct 20;281(42):32015-24
16923812
Mol Microbiol. 2005 Aug;57(3):629-39
16045609
J Biol Chem. 2007 Oct 5;282(40):29170-7
17640875
FASEB J. 2001 May;15(7):1326-8
11344129
PLoS Biol. 2008 Mar 25;6(3):e67
18366254
Structure. 2007 Aug;15(8):915-27
17697997
Science. 1991 Oct 25;254(5031):539-44
1948029
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
Methods Enzymol. 1997;276:307-26
27754618
FEMS Microbiol Lett. 2001 Sep 11;203(1):11-21
11557134
J Mol Biol. 2005 Oct 21;353(2):242-55
16169010
Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14422-7
16186483
Mol Microbiol. 2001 Mar;39(6):1452-63
11260463
J Mol Biol. 2007 Sep 21;372(3):774-97
17681537
J Bacteriol. 2005 Feb;187(4):1441-54
15687209
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17084-9
15569936
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Mol Microbiol. 2008 Sep;69(6):1358-72
18631241
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4884-7
1534409
Nat Struct Biol. 2002 Oct;9(10):771-8
12352954
Mol Microbiol. 1998 Apr;28(2):249-64
9622351
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2839-44
16477007